BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 17008927)

  • 1. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.
    Geier A; Fickert P; Trauner M
    Nat Clin Pract Gastroenterol Hepatol; 2006 Oct; 3(10):574-85. PubMed ID: 17008927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis and cholestasis.
    Fuchs M; Sanyal AJ
    Clin Liver Dis; 2008 Feb; 12(1):151-72, ix. PubMed ID: 18242502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between cholestasis and infection.
    Tănăsescu C
    Rom J Gastroenterol; 2004 Mar; 13(1):23-7. PubMed ID: 15054522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
    Luketic VA; Sanyal AJ
    Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor outcome in progressive sclerosing cholangitis after septic shock.
    Kulaksiz H; Heuberger D; Engler S; Stiehl A
    Endoscopy; 2008 Mar; 40(3):214-8. PubMed ID: 18264887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sepsis associated cholestasis in adults].
    Levinson R; Horowitz M; Rapaport MJ
    Harefuah; 2001 Jun; 140(6):519-23, 565. PubMed ID: 11420855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of cholestasis.
    Zollner G; Trauner M
    Clin Liver Dis; 2008 Feb; 12(1):1-26, vii. PubMed ID: 18242495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic failure after injury - a common pathogenesis with sclerosing cholangitis?
    Zilkens C; Friese J; Köller M; Muhr G; Schinkel C
    Eur J Med Res; 2008 Jul; 13(7):309-13. PubMed ID: 18700186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
    Beuers U
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.
    Gelbmann CM; Rümmele P; Wimmer M; Hofstädter F; Göhlmann B; Endlicher E; Kullmann F; Langgartner J; Schölmerich J
    Am J Gastroenterol; 2007 Jun; 102(6):1221-9. PubMed ID: 17531010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular pathogenesis of cholestasis in sepsis.
    Bhogal HK; Sanyal AJ
    Front Biosci (Elite Ed); 2013 Jan; 5(1):87-96. PubMed ID: 23276972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPS induces the TNF-alpha-mediated downregulation of rat liver aquaporin-8: role in sepsis-associated cholestasis.
    Lehmann GL; Carreras FI; Soria LR; Gradilone SA; Marinelli RA
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G567-75. PubMed ID: 18174273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac dysfunction in severe sepsis and septic shock.
    Zanotti-Cavazzoni SL; Hollenberg SM
    Curr Opin Crit Care; 2009 Oct; 15(5):392-7. PubMed ID: 19633546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathology of cholestasis.
    Li MK; Crawford JM
    Semin Liver Dis; 2004 Feb; 24(1):21-42. PubMed ID: 15085484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestasis in patients with acquired immunodeficiency syndrome: a surgeon's perspective.
    Liu KJ; Atten MJ; Donahue PE
    Am Surg; 1997 Jun; 63(6):519-24. PubMed ID: 9168766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of primary sclerosing cholangitis].
    Stiehl A; Benz C; Sauer P
    Praxis (Bern 1994); 2000 May; 89(22):975-7. PubMed ID: 10893998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Let there be bile"--understanding hepatic injury in cholestasis.
    Sokol RJ; Devereaux M; Dahl R; Gumpricht E
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S4-9. PubMed ID: 16819400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ursodeoxycholic acid treatment for cholestasis in liver transplant recipients.
    Rafael E; Duraj F; Rudström H; Wilczek H; Ericzon B
    Transplant Proc; 1995 Dec; 27(6):3501-2. PubMed ID: 8540069
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver in sepsis and systemic inflammatory response syndrome.
    Szabo G; Romics L; Frendl G
    Clin Liver Dis; 2002 Nov; 6(4):1045-66, x. PubMed ID: 12516206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.